08:30 AM EST, 01/13/2025 (MT Newswires) -- Context Therapeutics ( CNTX ) said Monday it has appointed Andy Pasternak as chairman of its board of directors, succeeding Richard Berman who stepped down on Jan. 12.

Pasternak currently serves as an advisory partner at Bain & Company, the company said.

Shares of Context Therapeutics ( CNTX ) were down nearly 4% in recent Monday premarket activity.